Ftse Mib
33.770,05
0,07%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
58.825,23
1,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oramed Pharmaceuticals Inc (ORMP) Oramed Pharmaceuticals Inc (ORMP) Notizie

Oramed Pharmaceuticals Inc

ORMP
2,345
0,005 (0,21%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:00:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/3/202414:00GLOBEScilex Holding Company Announces Repayment in Full of the..
06/3/202423:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202414:42EDGAR2Form 8-K - Current report
20/2/202414:30PRNUSOramed Letter to Shareholders
30/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:45EDGAR2Form 8-K - Current report
19/1/202422:45EDGAR2Form 8-K - Current report
08/1/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202419:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/12/202315:26EDGAR2Form 8-K - Current report
18/12/202322:45EDGAR2Form 8-K - Current report
09/11/202323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/9/202322:34EDGAR2Form 8-K - Current report
22/9/202317:38PRNUSSorrento Therapeutics, Inc. Announces the Consummation of..
22/9/202300:11PRNUSOramed Announces $101,875,000 Short-Term Senior Secured Note..
21/9/202322:05GLOBEScilex Holding Company Announces the Consummation of the..
13/9/202315:00GLOBEScilex Holding Company Enters into Non-Binding Term Sheets..
13/9/202314:47EDGAR2Form 8-K - Current report
10/8/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:30EDGAR2Form 8-K - Current report
07/8/202315:20EDGAR2Form 8-K - Current report
02/8/202313:45PRNUSOramed Signs Term Sheet with HTIT to Create a Joint Venture..
13/7/202323:00EDGAR2Form 8-K - Current report
20/6/202313:55PRNUSOramed to Present at the 83rd American Diabetes Association..
18/5/202313:55PRNUSOramed to Present at Novel Therapies for Type 2 Diabetes &..
15/5/202315:05PRNUSOramed Announces that its Chinese Partner, HTIT, has..
Apertura: 2,31 Min: 2,24 Max: 2,375
Chiusura: 2,34

La tua Cronologia

NASDAQ
ORMP
Oramed Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network